Peter Sheppard, Genpact, explains how reimagining operations helps pharmaceutical companies refocus resources
According to Peter Sheppard, Genpact, R&D needs to build a pipeline that delivers new therapeutic options
Think tank: refocusing resources
Peter Sheppard, Genpact, explains how reimagining operations helps pharmaceutical companies refocus resources
Published:
|
3 min read
Last updated:
Sign up to our newsletter
The week's biggest stories from this industry, direct to your inbox.